4. Definition 1,16:-
“Liposomes are defined as structure consisting of
one or more concentric spheres of lipid bilayers separated by
water or aqueous buffer compartments”.
4
12. It should be biodegradable, biocompatible, and
flexible. It can carry both water and lipid soluble
drugs.
The drugs can be stabilized from oxidation.
It should be improve the protein stabilization.
It provides controlled hydration,sustained release,
targeted drug delivery or site specific drug
delivery.
Stabilization of entrapped drug from hostile
environment.
Alter pharmacokinetics and pharmacodynamics
of drugs.
It can be administered through various routes.
It can incorporate micro and macro molecules
Advantages 10-18 :-
12
13. It has stability
It has solubility
It has short half life
The phospholipids undergoes
oxidation, hydrolysis
Leakage and fusion
It is high production cost
Some time allergic reactions
may occur to liposomal
constituents
Disadvantages 10-18 :-
13
36. 1) Aulton ME. Pharmaceutics-The science of dosage
form design, 2002, 2nd edit.
2) Banker S. Modern pharmaceutics, 2009, vol.121, 4th
edi., 275
3) Vyas S.P. & Khar R.K. “Targeted & controlled drug
delivery : Novel carrier system”. CBS publishers and
distributors, 2007.
4) Ansels ,Pharmaceutical dosage forms& Drug
delivery system,8th edi.
36
37. 5) Lidgate DM, Felgner PL, In vitro and in vivo studies
evaluating a liposome system for drug solubilisation. Pharm
Res 1988; 5: 759–764.
6) P, Bilandi A, Akanksha M, Kapoor B, Seth GL,
BihaHimanshu A, Sitasharan P, Singhai AK: Liposomes as
drug carriers. Int J Pharm Liposomes System 2011,
2(7):945–951.
7) Kataria S, Sandhuni SD:Stealth liposomes: a review. Int J
Res Art Pharm, 2011, 2(5):1534–1538
8) Jessy S,Vinay B, Novel delivary system.Int.j pharm bio sci
2013 Jan(1):150-160
37
38. 9) Barain, H. & Montazer, M,A Review on Applications
of Liposomes in Textil Processing. of Liposome Res,
2008 ;18 (3) 249-262
10) Anna J,Liposomes,J Pharm Sci. & Res. 2013,5(9)
181- 183
11)Patel N,Panda S,Liposomes drug delivary system.J
Pharm Sci Bio Res 2012;2(4):169-175
12) Thulasiramaraju T,Sudhakar b, Liposomes.A Novel
drug delivary system.Int J Bio Pharm 2012;3(1):5-16
13) Kulkarni p,Yadav j. Liposomes.A Novel drug
delivary system.Int J Curr Peper Res2011 ;3(2),10
38
39. 14) Harashima, H., Sakata, K., Funato, K., Kiwada, H.,
1994.Enhanced hepatic uptake of liposomes through
complement activation depending on the size of
liposomes.Pharm. Res. 11,402-406.
15) Sharma A.Liposome in drug delivery progress and
limitation. Int j pharm. 1997; 154;123-140.
16) Abdus S. Liposome drug delivery system
an update review. Current drug delivery.2007; 4; 297-
305
17) Mansoori and Agrawal, Liposome drug delivery
system ,Int J Art Res Pharm Bio, 2012; Vol.2 (4):453-
464
39
40. 18) Shashi K., Satinder K, Bharat P. A Complete
Review on Liposomes. Int Res J Pharm 2012;3(7)
10-16
19) Lasic D. Mechanism of liposome formation
Journal of liposome research. 1995; 5(3); 431-441.
20) Lasic D. Mechanism of liposome formation
.Journal of liposome research.1995; 5(3); 431-441.
21)www.slideshare.com
22) www.authorstream.com
40